Mehiläinen acquires InMedica Group, the largest private healthcare provider in Lithuania

Press Release, 9 January, 2025

Mehiläinen, Finland’s largest social care and healthcare provider, with a fast-growing international presence, today announces that it has signed an agreement to acquire InMedica Group, the largest private healthcare provider in Lithuania. The transaction is subject to approval by the authorities. Expansion into Lithuania aligns with Mehiläinen’s growth strategy and will make Mehiläinen the largest private healthcare provider in the Baltic countries.

InMedica Group is a medical network that offers primary, specialist, dental, and hospital care, as well as mental health services and diagnostics across Lithuania. InMedica Group serves a diverse range of patients, including individual customers, corporations, and those covered by public health insurance. With over 3,500 employees and 89 facilities, the company provides over 2.7 million physician visits annually and is a primary healthcare provider for more than 310,000 patients. InMedica Group’s revenue is expected to exceed EUR150 million in 2024.

InMedica Group’s sellers are the leading private equity fund in the Baltics, INVL Baltic Sea Growth Fund, AB City, a private group of healthcare and pharmaceutical companies, and the private company Litgaja, controlled by InMedica’s founding entrepreneur, CEO Kęstutis Broniukaitis. The transaction is expected to be the largest healthcare services transaction in the history of Baltic mergers and acquisitions.

– This is a landmark transaction for our fund and its investors, as well as for the entire Lithuanian healthcare market. As a fund, we have fulfilled our mission – we have created the right conditions for a relatively small business to become a market leader and an integral part of the healthcare system. After evaluating potential investors, we believe that Mehiläinen is the best possible next owner for the InMedica Group, as it has exceptional resources, capabilities, and the corporate culture to support InMedica Group’s continued growth and development, says Nerijus Drobavičus, partner at INVL Baltic Sea Growth Fund and Chairman of the Board at InMedica.

InMedica Group’s service portfolio and business model align closely with Mehiläinen’s, offering a solid foundation for future collaboration.

– InMedica Group is thrilled to join forces with Mehiläinen Group. Mehiläinen has been at the forefront of developing digital healthcare and is a trusted name in the industry. This partnership is an important milestone in our mission to improve healthcare services for patients in Lithuania, comments InMedica Group CEO, Kęstutis Broniukaitis.

– The private healthcare market in Lithuania is growing rapidly, and InMedica Group is a high-quality market leader with an excellent reputation. I’m excited to work with Kęstutis and the management team. Together, we can continue the successful growth and further enhance the services provided, comments Andreas Taalas, Mehiläinen Business Line Director for the Baltic region.

The transaction will not have a direct impact on InMedica Group’s personnel or patients, and the day-to-day operations will continue as usual, ensuring a seamless transition for all stakeholders. The transaction will enter into force on approval by the authorities.